Evidence map›Paper›PMID 30459197›Full record

ArticlemBio2018

Prion Seeds Distribute throughout the Eyes of Sporadic Creutzfeldt-Jakob Disease Patients.

Christina D Orrù, Katrin Soldau, Christian Cordano, Jorge Llibre-Guerra, Ari J Green, Henry Sanchez, Bradley R Groveman, Steven D Edland, Jiri G Safar, Jonathan H Lin and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Tracking Prions by RT-QuIC: An Update.Sub-cellular biochemistry · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Christina D Orrù *Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, Montana, USA.
Katrin Soldau *Department of Pathology, University of California, San Diego, La Jolla, California, USA.
Christian CordanoDepartment of Neurology, Multiple Sclerosis Center, University of California, San Francisco (UCSF), San Francisco, California, USA.
Jorge Llibre-GuerraCognitive and Behavioral Research Unit, National Institute of Neurology, Havana, Cuba.
Ari J GreenDepartment of Neurology, Multiple Sclerosis Center, University of California, San Francisco (UCSF), San Francisco, California, USA.
Henry SanchezDepartment of Pathology, University of California, San Francisco (UCSF), San Francisco, California, USA.
Bradley R GrovemanLaboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, Montana, USA.
Steven D EdlandDepartment of Family Medicine & Public Health, University of California, San Diego, La Jolla, California, USA.
Jiri G SafarDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
Jonathan H LinDepartment of Pathology, University of California, San Diego, La Jolla, California, USA.
Byron CaugheyLaboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Hamilton, Montana, USA bcaughey@niaid.nih.gov michael.geschwind@ucsf.edu csigurdson@ucsd.edu.
Michael D GeschwindDepartment of Neurology, Memory and Aging Center, University of California, San Francisco (UCSF), San Francisco, California, USA bcaughey@niaid.nih.gov michael.geschwind@ucsf.edu csigurdson@ucsd.edu.
Christina J SigurdsonDepartment of Pathology, University of California, San Diego, La Jolla, California, USA bcaughey@niaid.nih.gov michael.geschwind@ucsf.edu csigurdson@ucsd.edu.
University of California, San Diego · USUniversity of California, San Francisco · USNational Institute of Allergy and Infectious Diseases · USCase Western Reserve University · USNational Institutes of Health · USUniversity Memory and Aging Center · US

Funding

Detection of PrionsZIAAI001086 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CAUGHEY, BYRON · 2009 to 2025
$18.1M
Predicting progression of human prion diseaseR01AG031189 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GESCHWIND, MICHAEL D · 2008 to 2017
$5.7M
Mechanisms of Prion Aggregation and Species BarriersR01NS069566 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ESKO, JEFFREY D, RAVITS, JOHN · 2011 to 2025
$5.7M
Mechanisms of Prion SpreadR01NS076896 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2012 to 2021
$3.4M
Protein Homeostasis and Proteotoxicity MechanismsR01NS088485 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LIN, JONATHAN · 2015 to 2024
$3.0M
Mechanisms of Prion Spread and Neuronal ToxicityR37NS076896 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Christina Sigurdson · 2023 to 2026
$2.6M
Probing prion clearance through interstitial fluid and perivascular pathwaysR21NS110409 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2018 to 2019
$433k
Molecular basis of spongiform encephalopathy in prion diseaseR21NS105498 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIGURDSON, CHRISTINA · 2018 to 2019
$432k
Intramural NIH HHS ZIA AI001086NIA NIH HHS R01 AG031189NINDS NIH HHS R01 NS069566NINDS NIH HHS R01 NS076896NINDS NIH HHS R01 NS088485NINDS NIH HHS R21 NS105498NINDS NIH HHS R21 NS110409NINDS NIH HHS R37 NS076896
6 · The paper itself

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common prion disease in humans and has been iatrogenically transmitted through corneal graft transplantation. Approximately 40% of sCJD patients develop visual or oculomotor symptoms and may seek ophthalmological consultation. Here we used the highly sensitive real-time quaking-induced conversion (RT-QuIC) assay to measure postmortem prion seeding activities in cornea, lens, ocular fluid, retina, choroid, sclera, optic nerve, and extraocular muscle in the largest series of sCJD patient eyes studied by any assay to date. We detected prion seeding activity in 100% of sCJD eyes, representing three common sCJD subtypes, with levels varying by up to 4 log-fold among individuals. The retina consistently showed the highest seed levels, which in some cases were only slightly lower than brain. Within the retina, prion deposits were detected by immunohistochemistry (IHC) in the retinal outer plexiform layer in most sCJD cases, and in some eyes the inner plexiform layer, consistent with synaptic prion deposition. Prions were not detected by IHC in any other eye region. With RT-QuIC, prion seed levels generally declined in eye tissues with increased distance from the brain, and yet all corneas had prion seeds detectable. Prion seeds were also present in the optic nerve, extraocular muscle, choroid, lens, vitreous, and sclera. Collectively, these results reveal that sCJD patients accumulate prion seeds throughout the eye, indicating the potential diagnostic utility as well as a possible biohazard.

Indexed as

AgedAutopsyBrainCreutzfeldt-Jakob SyndromeEyeFemaleHumansImmunohistochemistryMaleMiddle AgedPrion DiseasesPrionsRetinaPrionsCreutzfeldt-Jakob diseaseeyeprionRT-QuIC

Identifiers

PMID30459197
PMCPMC6247090
OpenAlexW2901005536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.